# EDGAR Filing Document

**Accession Number:** 0001590144
**File Stem:** 0001590144-23-000015
**Filing Date:** 2023-2
**Character Count:** 11143
**Document Hash:** dd44b39f83f6fd77713b5b058d7b37aa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001590144-23-000015.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001590144-23-000015

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Apyx Medical Corp
- **CENTRAL INDEX KEY:** 0000719135
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 112644611
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-35626
- **FILM NUMBER:** 23627431

**BUSINESS ADDRESS:**
- **STREET 1:** 5115 ULMERTON ROAD
- **CITY:** CLEARWATER
- **STATE:** FL
- **ZIP:** 33760
- **BUSINESS PHONE:** 7273842323

**MAIL ADDRESS:**
- **STREET 1:** 5115 ULMERTON ROAD
- **CITY:** CLEARWATER
- **STATE:** FL
- **ZIP:** 33760

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BOVIE MEDICAL Corp
- **DATE OF NAME CHANGE:** 20150319

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BOVIE MEDICAL CORP
- **DATE OF NAME CHANGE:** 19990216

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AN CON GENETICS INC
- **DATE OF NAME CHANGE:** 19920703
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PURA VIDA INVESTMENTS, LLC
- **CENTRAL INDEX KEY:** 0001590144
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 512 W 22ND STREET
- **STREET 2:** 7TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011
- **BUSINESS PHONE:** 646-597-6995

**MAIL ADDRESS:**
- **STREET 1:** 512 W 22ND STREET
- **STREET 2:** 7TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10011

```

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(AMENDMENT NO. 1)*

APYX MEDICAL CORPORATION
(Name of Issuer)

Common Stock, $0.001 par value per share
(Title of Class of Securities)

03837C106
(CUSIP Number)

December 31, 2022
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

       [     ] Rule 13d-1(b)
       [ X ] Rule 13d-1(c)
       [     ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).

CUSIP No. 03837C106

13G

Page 2 of 8 Pages

1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Pura Vida Investments, LLC

2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a) [    ]
(b) [ x ]
3.
SEC USE ONLY

4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER

 0

6.
SHARED VOTING POWER

2,287,560*

7.
SOLE DISPOSITIVE POWER

 0

8.
SHARED DISPOSITIVE POWER

2,287,560*

9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,287,560*

10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [  ]

11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 6.61%**

12.
TYPE OF REPORTING PERSON (see instructions)

 IA

CUSIP No. 03837C106

13G

Page 3 of 8 Pages

1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Efrem Kamen

2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a) [    ]
(b) [ x ]
3.
SEC USE ONLY

4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 USA

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER

 0

6.
SHARED VOTING POWER

2,287,560*

7.
SOLE DISPOSITIVE POWER

 0

8.
SHARED DISPOSITIVE POWER

 2,287,560*

9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

2,287,560*

10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [  ]

11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

6.61%**

12.
TYPE OF REPORTING PERSON (see instructions)

 IN, HC

CUSIP No. 03837C106

13G

Page 4 of 8 Pages

1.
NAMES OF REPORTING PERSONS OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

Pura Vida Master Fund, Ltd.

2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a) [    ]
(b) [ x ]
3.
SEC USE ONLY

4.
CITIZENSHIP OR PLACE OF ORGANIZATION
 USA

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER

 0

6.
SHARED VOTING POWER

1,051,600

7.
SOLE DISPOSITIVE POWER

 0

8.
SHARED DISPOSITIVE POWER

 1,051,600

9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,051,600

10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions) [  ]

11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

3.04%**

12.
TYPE OF REPORTING PERSON (see instructions)

 OO

CUSIP No. 03837C106

13G

Page 5 of 8 Pages

Item 1.

(a)
Name of Issuer

APYX MEDICAL CORPORATION

(b)
Address of Issuers Principal Executive Offices

5115 Ulmerton Road, Clearwater, FL 33760

Item 2.

(a)
Name of Person Filing

Pura Vida Investments, LLC
Efrem Kamen
Pura Vida Master Fund, Ltd.
(collectively, the "Filers").

(b)
The address of the principal place of the Filers is located at:

Pura Vida Investments, LLC
512 West 22nd Street, 7th Floor
New York, NY 10011

(c)
 For citizenship of Filers, see Item 4 of the cover sheet for each Filer.

(d)
Title of Class of Securities

Common Stock, $0.001 par value per share

(e)
CUSIP Number

03837C106

Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or
(c), check whether the person filing is a:

(a)
[  ]
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)
[  ]
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)
[  ]
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)
[  ]
Investment company registered under section 8 of the Investment Company Act of
1940 (15 U.S.C. 80a-8).

(e)
[x]
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

(f)
[  ]
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)
(ii)(F);

(g)
[  ]
A parent holding company or control person in accordance with Rule 13d-1(b)(1)
(ii)(G);

(h)
[  ]
A savings associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);

(i)
[  ]
A church plan that is excluded from the definition of an investment company
under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)
[  ]
Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
CUSIP No. 03837C106

13G

Page 6 of 8 Pages

Item 4. Ownership.

(a) Amount beneficially owned: Pura Vida Investments LLC 2,287,560 * shares
Efrem Kamen 2,287,560 * shares Pura Vida Master Fund, Ltd. 1,051,600
(b) Percent of class: Pura Vida Investments LLC 6.61%** Efrem Kamen 6.61%**
Pura Vida Master Fund, Ltd. 3.04%**
(c) Number of shares as to which the person has:
       (i) Sole power to vote or to direct the vote 0
(ii) Shared power to vote or to direct the vote Pura Vida Investments LLC
2,287,560* shares Efrem Kamen 2,287,560* shares Pura Vida Master Fund, Ltd.
1,051,600
(iii) Sole power to dispose or to direct the disposition of 0
(iv) Shared power to dispose or to direct the disposition of Pura Vida
Investments, LLC 2,287,560* shares Efrem Kamen 2,287,560* shares Pura Vida
Master Fund, Ltd. 1,051,600

*Shares reported herein are owned by Pura Vida Master Fund, Ltd.
(the "Pura Vida Master Fund") and certain separately managed accounts
(the "Managed Accounts," collectively the "Client Accounts"). Pura Vida
Investments, LLC ("PVI") serves as the investment manager or sub-adviser
to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
Efrem Kamen serves as the managing member of PVI. By virtue of these
relationships, the Reporting Persons may be deemed to have shared voting
and dispositive power with respect to the Shares owned directly by the Pura
Vida Master Fund and the Managed Accounts. This report shall not be deemed
an admission that the Reporting Persons are beneficial owners of the Shares
for purposes of Section 13 of the Securities Exchange Act of 1934, as amended,
or for any other purpose. Each of the Reporting Persons disclaims beneficial
ownership of the Shares reported herein except to the extent of the Reporting
Persons pecuniary interest therein.

**The percentages herein are calculated based upon 34,597,822 shares of
Common Stock of the Issuer outstanding per the Issuers Form 10-Q filed with
the Securities and Exchange Commission on November 9, 2022

Item 5. Ownership of Five Percent or Less of a Class.

N/A

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

N/A

Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company.

N/A

CUSIP No. 03837C106

13G

Page 7 of 8 Pages

Item 8. Identification and Classification of Members of the Group.

N/A

Item 9. Notice of Dissolution of Group.

N/A

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or
as a participant in any transaction having that purpose or effect.

Exhibits.

Exhibit A Joint Filing Agreement.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2023

Pura Vida Investments, LLC

By: /s/ Efrem Kamen, Managing Member

Pura Vida Master Fund, Ltd.

By: /s/ Efrem Kamen, Managing Member

CUSIP No. 03837C106

13G

Page 8 of 8 Pages

EXHIBIT A
AGREEMENT REGARDING JOINT FILING
OF STATEMENT ON SCHEDULE 13D OR 13G

The undersigned hereby consent and agree to file a joint statement on Schedule
13G under the Securities Exchange Act of 1934, as amended, with respect to the
Pura Vida Investments, LLC. beneficially owned by them, together with any or
all amendments thereto, when and if appropriate. The parties hereto further
consent this Statement pursuant to Rule 13d-1(k)(1)(iii) as an exhibit to
Schedule 13G, thereby incorporating the same into such Schedule 13G.

Dated: February 14, 2023

Pura Vida Investments, LLC

By: /s/ Efrem Kamen, Managing Member

Pura Vida Master Fund, Ltd.

By: /s/ Efrem Kamen, Managing Member

```